Management of hepatitis B in liver transplant patients
- PMID: 15599213
Management of hepatitis B in liver transplant patients
Abstract
Recent therapeutic advances have allowed for routine transplantation of patients with hepatitis B. The first major breakthrough was the use of hepatitis B immune globulin, which reduced posttransplantation hepatitis B recurrence rates to approximately 20%. More recently, the nucleoside analogues lamivudine and adefovir have shown efficacy in the treatment of hepatitis B both before and after liver transplantation. Management strategies are evolving that include initiation of a nucleoside analogue pretransplantation in patients with active viral replication. Combination therapy with hepatitis B immune globulin and a nucleoside analogue is being used posttransplantation. In addition, there is interest in the use of therapeutic vaccination posttransplantation. In this report, we review strategies for managing HBV in the setting of liver transplantation and detail data regarding patient outcomes.
Similar articles
-
Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.Hepatobiliary Pancreat Dis Int. 2005 Nov;4(4):509-14. Hepatobiliary Pancreat Dis Int. 2005. PMID: 16286253 Review.
-
Posttransplantation: future therapies.Semin Liver Dis. 2000;20 Suppl 1:19-24. Semin Liver Dis. 2000. PMID: 10895440 Review.
-
Management of hepatitis B in liver transplant recipients.J Viral Hepat. 2007 Nov;14 Suppl 1:37-44. doi: 10.1111/j.1365-2893.2007.00916.x. J Viral Hepat. 2007. PMID: 17958641 Review.
-
Prophylaxis and treatment of recurrent hepatitis B after liver transplantation.Transplantation. 2003 Feb 15;75(3 Suppl):S41-4. doi: 10.1097/01.TP.0000047027.68167.07. Transplantation. 2003. PMID: 12589139 Review.
-
Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin/antiviral regimen?Liver Transpl. 2008 Oct;14 Suppl 2:S15-22. doi: 10.1002/lt.21614. Liver Transpl. 2008. PMID: 18825721 Review.
Cited by
-
The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.J Gastroenterol. 2017 Mar;52(3):366-375. doi: 10.1007/s00535-016-1240-y. Epub 2016 Jul 15. J Gastroenterol. 2017. PMID: 27422771
-
Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database.J Korean Med Sci. 2020 Feb 17;35(6):e36. doi: 10.3346/jkms.2020.35.e36. J Korean Med Sci. 2020. PMID: 32056398 Free PMC article.
-
Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis.J Korean Med Sci. 2019 Oct 7;34(38):e251. doi: 10.3346/jkms.2019.34.e251. J Korean Med Sci. 2019. PMID: 31583871 Free PMC article.
-
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.Ann Clin Microbiol Antimicrob. 2006 Apr 6;5:8. doi: 10.1186/1476-0711-5-8. Ann Clin Microbiol Antimicrob. 2006. PMID: 16600049 Free PMC article. Review.
-
Assessment of patient safety and the efficiency of facility utilization following simplified ultra-rapid intravenous infusion of hepatitis B immunoglobulin in a high-volume liver transplantation center.Ann Hepatobiliary Pancreat Surg. 2019 May;23(2):128-132. doi: 10.14701/ahbps.2019.23.2.128. Epub 2019 May 31. Ann Hepatobiliary Pancreat Surg. 2019. PMID: 31225413 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
